Inj multihance
Products billed under this code include Multihance.
Payment limit per 1 ML, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Multihance.
Payment limit per 1 ML, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Multihance | Bracco Diagnostics Inc. | 00270-5164-12 | 25 | $45.10 |
| Multihance | Bracco Diagnostics Inc. | 00270-5164-13 | 50 | $90.20 |
| Multihance | Bracco Diagnostics Inc. | 00270-5164-14 | 75 | $135.30 |
| Multihance | Bracco Diagnostics Inc. | 00270-5164-15 | 100 | $180.40 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $1.804 | +$0.013 | 1 ML | Inj multihance | v1, posted September 17, 2026 |
| 3Q26 | $1.791 | +$0.004 | 1 ML | Inj multihance | v1, posted September 15, 2026 |
| 2Q26 | $1.787 | −$0.012 | 1 ML | Inj multihance | v1, posted September 15, 2026 |
| 1Q26 | $1.799 | +$0.056 | 1 ML | Inj multihance | v1, posted September 15, 2026 |
| 4Q25 | $1.743 | $0.00 | 1 ML | Inj multihance | v1, posted September 8, 2026 |
| 3Q25 | $1.743 | −$0.072 | 1 ML | Inj multihance | v1, posted March 10, 2026 |
| 2Q25 | $1.815 | −$0.009 | 1 ML | Inj multihance | v1, posted March 10, 2026 |
| 1Q25 | $1.824 | +$0.009 | 1 ML | Inj multihance | v1, posted December 19, 2025 |
| 4Q24 | $1.815 | −$0.019 | 1 ML | Inj multihance | v1, posted June 11, 2025 |
| 3Q24 | $1.834 | +$0.013 | 1 ML | Inj multihance | v1, posted June 11, 2025 |
| 2Q24 | $1.821 | −$0.02 | 1 ML | Inj multihance | v1, posted March 11, 2025 |
| 1Q24 | $1.841 | +$0.022 | 1 ML | Inj multihance | v1, posted December 19, 2024 |
| 4Q23 | $1.819 | +$0.006 | 1 ML | Inj multihance | v1, posted October 10, 2024 |
| 3Q23 | $1.813 | −$0.021 | 1 ML | Inj multihance | v1, posted June 5, 2024 |
| 2Q23 | $1.834 | −$0.009 | 1 ML | Inj multihance | v1, posted February 23, 2024 |
| 1Q23 | $1.843 | −$0.057 | 1 ML | Inj multihance | v1, posted December 6, 2023 |
| 4Q22 | $1.90 | +$0.05 | 1 ML | Inj multihance | v1, posted June 22, 2023 |
| 3Q22 | $1.85 | −$0.003 | 1 ML | Inj multihance | v1, posted June 9, 2023 |
| 2Q22 | $1.853 | −$0.025 | 1 ML | Inj multihance | v1, posted December 14, 2022 |
| 1Q22 | $1.878 | +$0.011 | 1 ML | Inj multihance | v1, posted June 8, 2022 |
| 4Q21 | $1.867 | −$0.011 | 1 ML | Inj multihance | v1, posted June 2, 2022 |
| 3Q21 | $1.878 | +$0.071 | 1 ML | Inj multihance | v1, posted June 2, 2022 |
| 2Q21 | $1.807 | −$0.007 | 1 ML | Inj multihance | v1, posted March 1, 2022 |
| 1Q21 | $1.814 | – | 1 ML | Inj multihance | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.